ARCHIVES

GSK’s Pazopanib Benefits Similar to Sunitinib; Sponsor Points to More Favorable Safety Profile

This article is from The Cancer Letter archive.

Vol. 36 No. 8 | August 30, 2013

Download PDF Visit The Full Archive

Related Articles

Latest State Cancer Statistics Released.

January 14, 2005

FDA Approves Votrient For Renal Cell Carcinoma

October 23, 2009

NCAB Shaping Up, But Reverts to Nonsense When Discussing “Role Of The Board”

March 11, 1983

Study Links Native American Ancestry to Leukemia Relapse

February 25, 2011

Adding Velcade Increased Overall Survival By 13.3 Months at Five-Year Analysis

December 30, 2011

In Brief: Kessler Urges Cardiologists To Fight Teen Smoking; ODAC To Meet Dec. 14

December 1, 1995